Authors



Stephen A. Brunton, MD, Bobby Levy, MD

Latest:

Insulin as a strategy to optimize glycemic control in patients with type 2 diabetes

Treatment of type 2 diabetes should achieve and maintain euglycemia, thereby preventing complications from this progressive disease. Current antidiabetic therapies should be a part of a multimodal management program that includes diet, exercise, and blood pressure and lipid control. Oral antidiabetic drugs are still first-line therapy for type 2 diabetes, but intensification of therapy, including starting insulin, should occur every 2 to 3 months as needed to achieve euglycemia. The first insulin added is typically a basal insulin, which is effective in lowering fasting plasma glucose (FPG). A persistently elevated glycated hemoglobin (HgbA1C) level despite near or complete normalization of FPG, however, indicates postprandial hyperglycemia. In these cases, the addition of bolus insulin is required to reduce postprandial glucose (PPG). Several approaches to initiate and titrate insulin can be used based on FPG, PPG, HgbA1C, and patient factors.





Electrophysiology Center, Policlinico San Donato, University of Milan

Latest:

Integrating the existing emergency medical system with automated external defibrillators for out-of-hospital cardiac arrest

We investigated whether a program based on diffuse deployment of automated external defibrillators operated by trained volunteers and laypersons across the largest county in Italy would safely and effectively improve the current survival rate among patients with out-of-hospital cardiac arrest. Compared with historical control subjects, the new strategy resulted in a 3-fold increase in 1-year survival free of neurologic impairment.


Patrick McGee

Latest:

Systemic Lupus Erythematosus and Nonadjuvant H1N1 Vaccination

Clinicians have reported that influenza vaccination increases autoantibody production and/or disease activity in a significant proportion of patients with systemic lupus erythematosus (SLE).



Hetal A. Gandhi, MD

Latest:

Anomalous origin of the left anterior descending artery from a separate ostium of the right sinus of Valsalva with abnormal stress test

A 67-year-old man with positive results on a stress myocardial perfusion test was found to have isolated anomalous origin of the left anterior descending coronary artery from a separate coronary ostium of the right sinus of Valsalva. This anomalous artery was not stenotic and coursed over the anterior free wall of the right ventricle, in front of the pulmonary artery. It did not appear to have an intra-arterial or intramyocardial course.


Beth Walsh

Latest:

ACAAI 2011: Cutting Cat Dander and Allergic Response

Pets can cause a variety of health problems for those with sensitivities but there are environmental changes that can help, according to Dana Wallace, MD, PA, associate clinical professor, Nova Southeastern University.


Melinda Palma, MS IV

Latest:

Oral Morphine Versus Ibuprofen to Manage Post-fracture Pain in Children

Is orally administered morphine superior to ibuprofen for outpatient pain management for children with uncomplicated fractures?



Carmelo Lafuente-Lafuente, MD

Latest:

Maintaining sinus rhythm after cardioversion of atrial fibrillation

We performed a meta-analysis of the effect of long-term treatment with antiarrhythmic drugs for the prevention of recurrent atrial fibrillation after conversion to sinus rhythm. We found that several class IA, IC, and III drugs are effective in maintaining sinus rhythm, but virtually all of them increase adverse effects, including proarrhythmia. In addition, class IA drugs are associated with increased mortality. The final risk-benefit ratio of antiarrhythmic drugs on clinically relevant outcomes is still unclear.




Carolyn Colwell, LCSW-R, MSJ

Latest:

ACA Ruling a Big Win for Mental Health

The King v. Burwell US Supreme Court decision yesterday means that people who could have lost mental health insurance coverage don't have to worry.


Josh Weiner, CEO, Solutionreach

Latest:

Fighting the Spread of Dangerous Misinformation During the COVID-19 Pandemic

How providers can stop the spread of dangerous information during the COVID-19 pandemic.




Josh Weiner, CEO & President, Solutionreach

Latest:

Practices to Ensure the Best Communication Across the Patient Journey

What technology should be implemented to ensure a positive experience for patients?


Junichiro Hashimoto, MD, PhD

Latest:

Prognosis of "masked" hypertension vs. "white-coat" hypertension

We compared the prognosis of patients with "white-coat" hypertension (WCHT) with that of patients with "masked" hypertension (MHT). The 10-year composite risk of stroke morbidity and cardiovascular mortality for patients with WCHT was similar to the risk for patients with sustained normal blood pressure, whereas the risk was markedly increased for patients with MHT and sustained hypertension. This indicates that conventional blood pressure measurements may fail to distinguish some patients at high or low risk.


Isabelle C. Van Gelder, MD, for the RACE Investigators

Latest:

Sex-related differences in atrial fibrillation: Data from the RACE study

We evaluated the effects of rate control treatment versus sinus rhythm restoration and maintenance in patients with persistent atrial fibrillation in a substudy of the Rate Control Versus Electrical Cardioversion (RACE) trial. Rhythm control treatment was associated with greater cardiovascular morbidity and mortality in women. Because treatment did not improve quality of life in these patients, rate control may be considered as first-choice therapy for women.



William B. Kannel, MD, MPH

Latest:

New Framingham Heart Study global cardiovascular risk instruments for use in primary prevention of atherosclerotic events

Cardiovascular risk factors vary somewhat for each specific atherosclerotic cardiovascular disease event; however, there is sufficient commonality to enable crafting of a global CVD risk-assessment instrument that accurately predicts total CVD risk and the risk of its individual components.


Stephen P. Glasser, MD, is professor of preventive medicine

Latest:

Cardiovascular events in hypertension trials: A focus on perindopril

Pharmacologic inhibition of the renin-angiotensin aldosterone system (RAAS) has become a widely accepted ap­proach to lowering blood pressure (BP).


Edward Friedman, MD

Latest:

Where's the Love for Tablet PCs in Psychiatry?

Our most modern iteration of the portable, wirelessly connected, handwriting- and speech-recognition-capable computer is the "tablet PC."



Jurga Adomaityte, MD: From the division of general internal medicine/hospitalist program, The Johns Hopkins School of Medicine, Baltimore, MD.

Latest:

Non–ST-segment elevation ACS: Should all patients undergo cardiac catheterization?

We performed a systematic review and meta-analysis of all clinical trials comparing routine invasive strategy with selective invasive strategy in patients with non–ST-segment elevation acute coronary syndrome. We did not find either strategy to offer an advantage over the other, even when we excluded trials that did not use coronary stents and glycoprotein IIb/IIIa inhibitors.



James J. Maciejko, MS, PhD, FACC

Latest:

The Importance of Rare Disease Awareness Among Physicians

James J. Maciejko, MS, PhD, FACC, stresses the importance of rare disease awareness among physicians for proper diagnosis and treatment.

© 2024 MJH Life Sciences

All rights reserved.